Mercury Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 to consider and approve the Audited Financial Results for the quarter and financial Year ended on 31st March, 2025; To Recommend Dividend, if any; an appointment of Secretarial Auditor for the Financial Year 2025-26, subject to approval of shareholders; An appointment of Internal Auditor for the FY 2025-26; an appointment of Cost Auditor for the FY 2025-26; To fix the date, time and venue for the 44th Annual General Meeting and approve the draft notice of the 44th Annual General Meeting of the Company; any other items of Agenda, if any.
The above information is a part of company’s filings submitted to BSE.
